Lesson for the clinical nephrologist: renal involvement in a patient with polycythemia vera

Alon Bnaya^{1

2}, Aaron Ronson^{3

4}, Ofer Benjaminov^{5

4}, Linda Shavit^{6

4}

Affiliations

¹ Nephrology Unit, Shaare Zedek Medical Center, PO Box 3235, 91031, Jerusalem, Israel. alonb@szmc.org.il.
² Hadassah Hebrew University School of Medicine, Campus Ein Kerem, 9112102, Jerusalem, Israel. alonb@szmc.org.il.
³ Department of Hematology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem, Israel.
⁴ Hadassah Hebrew University School of Medicine, Campus Ein Kerem, 9112102, Jerusalem, Israel.
⁵ Department of Radiology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem, Israel.
⁶ Nephrology Unit, Shaare Zedek Medical Center, PO Box 3235, 91031, Jerusalem, Israel.

Alon Bnaya et al. J Nephrol. 2022 Nov.

. 2022 Nov;35(8):2123-2126.

doi: 10.1007/s40620-022-01324-x. Epub 2022 Apr 20.

Alon Bnaya^{1

2}, Aaron Ronson^{3

4}, Ofer Benjaminov^{5

4}, Linda Shavit^{6

4}

¹ Nephrology Unit, Shaare Zedek Medical Center, PO Box 3235, 91031, Jerusalem, Israel. alonb@szmc.org.il.
² Hadassah Hebrew University School of Medicine, Campus Ein Kerem, 9112102, Jerusalem, Israel. alonb@szmc.org.il.
³ Department of Hematology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem, Israel.
⁴ Hadassah Hebrew University School of Medicine, Campus Ein Kerem, 9112102, Jerusalem, Israel.
⁵ Department of Radiology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem, Israel.
⁶ Nephrology Unit, Shaare Zedek Medical Center, PO Box 3235, 91031, Jerusalem, Israel.

No abstract available

Keywords: Chronic kidney disease; Extramedullary hematopoiesis; Myeloproliferative neoplasm; Polycythemia vera; Proteinuria.

References

1. Baek SW, Moon JY, Ryu H, Choi YS, Song IC, Lee HJ, Yun HJ, Kim S, Jo DY (2018) Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study. Korean J Intern Med 33(4):790–797 - DOI
1. Fukuda Y, Araki M, Yamamoto K, Morishita S, Inano T, Misawa K, Ochiai T, Edahiro Y, Imai M, Yasuda H, Gotoh A, Ohsaka A, Komatsu N (2019) Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy. Haematologica 104(11):e506–e509 - DOI
1. Strati P, Glass WF, Abdelrahim M, Selamet U, Tchakarov A, Workeneh BT, Verstovsek S, Abudayyeh A (2019) Renal complications of primary myelofibrosis. Leuk Lymphoma 60(2):507–510 - DOI
1. Said SM, Leung N, Sethi S et al (2011) Myeloproliferative neoplasms cause glomerulopathy. Kidney Int 80:753–759 - DOI
1. Alexander MP, Nasr SH, Kurtin PJ et al (2015) Renal extramedullary hematopoiesis: interstitial and glomerular pathology. Mod Pathol 28:1574–1583 - DOI